Beyond weight loss and improvement of insulin resistance, the positive effects of GLP-1 agonists also seem to be multifactorial-mediated with additional pleiotropic effects, especially on improvement of cardiovascular disease. This evidence concerns the gene GCG and Insulin resistance.